| 產(chǎn)品編號(hào) | bs-0317R-Gold |
| 英文名稱(chēng) | Rabbit Anti-ILK-1/Gold Conjugated antibody |
| 中文名稱(chēng) | 膠體金標(biāo)記的整合素連接激酶-1抗體 |
| 別 名 | 59 kDa serine/threonine protein kinase; 59 kDa serine/threonine-protein kinase; ILK-2; ILK_HUMAN; Integrin linked Kinase; Integrin-linked protein kinase; DKFZp686F1765; EC 2.7.11.1; ILK 1; ILK 2; ILK; ILK1; ILK2; Integrin linked Kinase 2; Integrin linked protein kinase; p59; p59ILK. |
| 規(guī)格價(jià)格 | 100ul/2980元 購(gòu)買(mǎi) 大包裝/詢(xún)價(jià) |
| 說(shuō) 明 書(shū) | 100ul（10nm 15nm 35nm） |
| 研究領(lǐng)域 | 腫瘤 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | Human, Mouse, Rat, (predicted: Chicken, Dog, Cow, ) |
| 產(chǎn)品應(yīng)用 | IEM=1:20-200 ICA=1:20-200 ChIP=1:20-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 50kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 0.4mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human ILK-1 (351-400aa) |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.02M TBS(pH8.2) with 1% BSA, 0.03% Proclin300. |
| 保存條件 | Store at 2-8 oC for 3-6 months. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 |
background: Transduction of extracellular matrix signals through integrins influences intracellular and extracellular functions, and appears to require interaction of integrin cytoplasmic domains with cellular proteins. Integrin linked kinase (ILK), interacts with the cytoplasmic domain of beta 1 Integrin. ILK encodes a predicted 451 amino acid protein, with an apparent molecular weight of 59 kDa. The ILK protein is a serine/threonine protein kinase with 4 ankyrin like repeats. ILK regulates integrin mediated signal transduction. The ILK protein is important in different biological pathways such as cell adhesion, anchorage-dependent cell cycle progression, oncogenic transformation, and growth factor signaling. The kinase activity of ILK is low in non-activated cells; its activity is stimulated by cell-ECM interactions and by certain growth factors. 3 Negative regulation of ILK is mediated by two phosphatases: PTEN, a tumor suppressor lipid sphatase, and ILKAP, a PP2C protein phosphatase. In tumor cells that do not express PTEN protein, ILK is constitutively active. Function: Receptor-proximal protein kinase regulating integrin-mediated signal transduction. May act as a mediator of inside-out integrin signaling. Focal adhesion protein part of the complex ILK-PINCH. This complex is considered to be one of the convergence points of integrin- and growth factor-signaling pathway. Could be implicated in mediating cell architecture, adhesion to integrin substrates and anchorage-dependent growth in epithelial cells. Phosphorylates beta-1 and beta-3 integrin subunit on serine and threonine residues, but also AKT1 and GSK3B. Subunit: Interacts with cytoplasmic domain of beta 1 subunit of integrin. Could also interacts with beta 2, beta 3 and/or beta 5 subunit of integrin. Interacts (via ANK repeats) with LIMS1 and LIMS2. Interacts with parvins and probably TGFB1I1. Interacts (via ANK repeats) with EPHA1 (via SAM domain); stimulated by EFNA1 but independent of the kinase activity of EPHA1. Subcellular Location: Cell junction, focal adhesion. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Tissue Specificity: Highly expressed in heart followed by skeletal muscle, pancreas and kidney. Weakly expressed in placenta, lung and liver. Post-translational modifications: Autophosphorylated on serine residues. Similarity: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. Contains 5 ANK repeats. Contains 1 protein kinase domain. Database links: Entrez Gene: 3611 Human Entrez Gene: 16202 Mouse Omim: 602366 Human SwissProt: Q13418 Human SwissProt: O55222 Mouse Unigene: 5158 Human Unigene: 706355 Human Unigene: 274846 Mouse Unigene: 95042 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. ILK 是一種新發(fā)現(xiàn)的Ser/Thr蛋白激酶。ILK能夠通過(guò)與整合素β1亞單位的結(jié)合介導(dǎo)細(xì)胞與胞外基質(zhì)的連接，以依賴(lài)于PI3K的方式激活，并通過(guò)磷酸化下游底物PKB/AKT,GSK3等胞外信號(hào)的一項(xiàng)下游傳遞，對(duì)細(xì)胞的生長(zhǎng)，分化，遷移等進(jìn)行調(diào)控。由于ILK在胞內(nèi)外信號(hào)傳導(dǎo)中起著重要的作用。并且抑制ILK的活性能夠?qū)е录?xì)胞周期的停滯和細(xì)胞程序性死亡的啟動(dòng)，使其成為腫瘤治療和腫瘤藥物的理想靶位點(diǎn)。 該蛋白也表達(dá)與腎小球系膜細(xì)胞，正常足細(xì)胞ILK的高水平表達(dá)對(duì)足細(xì)胞功能起著重要的生理作用。DN 患者ILK表達(dá)明顯增加 ，暴露于高血糖的腎小球膜細(xì)胞的ILK 水平明顯升高, ILK 與整合素和其他連接蛋白都受到高血糖的調(diào)節(jié),并且促進(jìn)DN 患者腎小球基質(zhì)的沉積。 |
